Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 6072573, 12 pages
https://doi.org/10.1155/2017/6072573
Research Article

Barley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of Osteoclastogenesis

1Division of Crop Foundation, National Institute of Crop Science (NICS), Rural Development Administration (RDA), Jeonbuk 565-851, Republic of Korea
2Department of Biological Sciences, College of Natural Science, Chonbuk National University, Jeonbuk 561-756, Republic of Korea
3College of Crop Science and Biotechnology, Dankook University, Cheonan 330-714, Republic of Korea
4Division of Research Development and Education, National Institute of Chemical Safety, Ministry of Environment, Daejeon 305-343, Republic of Korea

Correspondence should be addressed to Woo Duck Seo; rk.aerok@2002dws

Received 7 March 2017; Revised 3 April 2017; Accepted 18 April 2017; Published 8 May 2017

Academic Editor: Vishal Chandra

Copyright © 2017 Sik-Won Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Manolagas and A. M. Parfitt, “What old means to bone,” Trends in Endocrinology and Metabolism, vol. 21, no. 6, pp. 369–374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. G. A. Rodan and T. J. Martin, “Therapeutic approaches to bone diseases,” Science, vol. 289, no. 5484, pp. 1508–1514, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Khosla and B. L. Riggs, “Pathophysiology of age-related bone loss and osteoporosis,” Endocrinology and Metabolism Clinics of North America, vol. 34, no. 4, pp. 1015–1030, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Feng and J. M. McDonald, “Disorders of bone remodeling,” Annual Review of Pathology, vol. 6, pp. 121–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Chrischilles, T. Shireman, and R. Wallace, “Costs and health effects of osteoporotic fractures,” Bone, vol. 15, no. 4, pp. 377–386, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. “Osteoporosis prevention, diagnosis, and therapy,” JAMA, 2001. View at Publisher · View at Google Scholar
  7. X. Feng, “RANKing intracellular signaling in osteoclasts,” IUBMB Life, vol. 57, no. 6, pp. 389–395, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Galibert, M. E. Tometsko, D. M. Andersen, D. Cosman, and W. C. Dougall, “The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-κB, a member of the TNFR superfamily,” Journal of Biological Chemistry, vol. 273, no. 51, pp. 34120–34127, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Takayanagi, “Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems,” Nature Reviews Immunology, vol. 7, no. 4, pp. 292–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Takayanagi, “Inflammatory bone destruction and osteoimmunology,” Journal of Periodontal Research, vol. 40, no. 4, pp. 287–293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Nakamura, N. Takahashi, E. Jimi, N. Udagawa, and T. Suda, “Regulation of osteoclast function,” Modern Rheumatology, vol. 22, no. 2, pp. 167–177, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Hooshmand and B. H. Arjmandi, “Viewpoint: dried plum, an emerging functional food that may effectively improve bone health,” Ageing Research Reviews, vol. 8, no. 2, pp. 122–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T.-H. Huang, R. C. Mühlbauer, C.-H. Tang et al., “Onion decreases the ovariectomy-induced osteopenia in young adult rats,” Bone, vol. 42, no. 6, pp. 1154–1163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Zhang, X.-O. Shu, H. Li et al., “Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women,” Archives of Internal Medicine, vol. 165, no. 16, pp. 1890–1895, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. R. C. Mühlbauer, A. Lozano, A. Reinli, and H. Wetli, “Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats,” Journal of Nutrition, vol. 133, no. 11, pp. 3592–3597, 2003. View at Google Scholar · View at Scopus
  16. J. Zhang, X. Xiao, Y. Dong, L. Shi, T. Xu, and F. Wu, “The anti-obesity effect of fermented barley extracts with Lactobacillus plantarum dy-1 and Saccharomyces cerevisiae in diet-induced obese rats,” Food & Function, vol. 8, no. 3, pp. 1132–1143, 2017. View at Publisher · View at Google Scholar
  17. S. Gul, S. Ahmed, N. Kifli et al., “Multiple pathways are responsible for anti-inflammatory and cardiovascular activities of Hordeum vulgare L.,” Journal of Translational Medicine, vol. 12, no. 1, 2014, article 316. View at Publisher · View at Google Scholar
  18. K.-C. Choi, J.-M. Hwang, S.-J. Bang et al., “Methanol extract of the aerial parts of barley (Hordeum vulgare) suppresses lipopolysaccharide-induced inflammatory responses in vitro and in vivo,” Pharmaceutical Biology, vol. 51, no. 8, pp. 1066–1076, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. G. Shah, B. G. Patel, S. B. Patel, and R. K. Patel, “Antiurolithiatic and antioxidant activity of Hordeum vulgare seeds on ethylene glycol-induced urolithiasis in rats,” Indian Journal of Pharmacology, vol. 44, no. 6, pp. 672–677, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Kamimura and T. Takashashi, “Procyanidin B-3, isolated from barley and identified as a hair-growth stimulant, has the potential to counteract inhibitory regulation by TGF-β1,” Experimental Dermatology, vol. 11, no. 6, pp. 532–541, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. R. Lupton, M. C. Robinson, and J. L. Morin, “Cholesterol-lowering effect of barley bran flour and oil,” Journal of the American Dietetic Association, vol. 94, no. 1, pp. 65–70, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Park, J.-E. Ra, K. H. Seo et al., “Identification and evaluation of flavone-glucosides isolated from barley sprouts and their inhibitory activity against bacterial neuraminidase,” Natural Product Communications, vol. 9, no. 10, pp. 1469–1472, 2014. View at Google Scholar · View at Scopus
  23. W. D. Seo, H. J. Yuk, M. J. Curtis-Long et al., “Effect of the growth stage and cultivar on policosanol profiles of barley sprouts and their adenosine 5′-monophosphate-activated protein kinase activation,” Journal of Agricultural and Food Chemistry, vol. 61, no. 5, pp. 1117–1123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-W. Choi, J.-T. Yeon, B. J. Ryu et al., “Repositioning potential of pak4 to osteoclastic bone resorption,” Journal of Bone and Mineral Research, vol. 30, no. 8, pp. 1494–1507, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-T. Yeon, K.-J. Kim, S. W. Chun et al., “KCNK1 inhibits osteoclastogenesis by blocking the Ca2+ oscillation and JNK-NFATc1 signaling axis,” Journal of Cell Science, vol. 128, no. 18, pp. 3411–3419, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Rozen and H. Skaletsky, “Primer3 on the WWW for general users and for biologist programmers,” Methods in Molecular Biology, vol. 132, pp. 365–386, 2000. View at Google Scholar · View at Scopus
  27. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Choi, K. Lee, J. H. Lee et al., “Suppression of Akt-HIF-1α signaling axis by diacetyl atractylodiol inhibits hypoxia-induced angiogenesis,” BMB Reports, vol. 49, no. 9, pp. 508–513, 2016. View at Publisher · View at Google Scholar
  29. S.-W. Choi, Y.-J. Son, J.-M. Yun, and S. H. Kim, “Fisetin inhibits osteoclast differentiation via downregulation of p38 and c-Fos-NFATc1 signaling pathways,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 810563, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Dannemann, K. W. Grätz, M. O. Riener, and R. A. Zwahlen, “Jaw osteonecrosis related to bisphosphonate therapy. A severe secondary disorder,” Bone, vol. 40, no. 4, pp. 828–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. P. H. Meier, T. V. Perneger, R. Stern, R. Rizzoli, and R. E. Peter, “Increasing occurrence of atypical femoral fractures associated with bisphosphonate use,” Archives of Internal Medicine, vol. 172, no. 12, pp. 930–936, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Scalbert, C. Manach, C. Morand, and C. Remesy, “Dietary polyphenols and the prevention of diseases,” Critical Reviews in Food Science and Nutrition, vol. 45, no. 4, pp. 287–306, 2005. View at Publisher · View at Google Scholar
  33. Y.-H. Lee, J.-H. Kim, S. H. Kim et al., “Barley sprouts extract attenuates alcoholic fatty liver injury in mice by reducing inflammatory response,” Nutrients, vol. 8, no. 7, article no. 440, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. A. R. Byun, H. Chun, J. Lee, S. W. Lee, H. S. Lee, and K. W. Shim, “Effects of a dietary supplement with barley sprout extract on blood cholesterol metabolism,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 473056, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Takano, T. Kamiya, H. Tomozawa et al., “Insoluble fiber in young barley leaf suppresses the increment of postprandial blood glucose level by increasing the digesta viscosity,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, article 137871, 10 pages, 2013. View at Publisher · View at Google Scholar
  36. J. A. Benedet, H. Umeda, and T. Shibamoto, “Antioxidant activity of flavonoids isolated from young green barley leaves toward biological lipid samples,” Journal of Agricultural and Food Chemistry, vol. 55, no. 14, pp. 5499–5504, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. W. J. Boyle, W. S. Simonet, and D. L. Lacey, “Osteoclast differentiation and activation,” Nature, vol. 423, no. 6937, pp. 337–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Arai, T. Mizoguchi, S. Harada et al., “Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment,” Journal of Cell Science, vol. 125, part 12, pp. 2910–2917, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Fleischmann, F. Hafezi, C. Elliott et al., Fra-1 replaces c-Fos-dependent functions in mice, Genes development, vol. 14.
  40. H. Takayanagi, S. Kim, T. Koga et al., “Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts,” Developmental Cell, vol. 3, no. 6, pp. 889–901, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Rao, C. Luo, and P. G. Hogan, “Transcription factors of the NFAT family: regulation and function,” Annual Review of Immunology, vol. 15, pp. 707–747, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. H. C. Blair, L. J. Robinson, and M. Zaidi, “Osteoclast signalling pathways,” Biochemical and Biophysical Research Communications, vol. 328, no. 3, pp. 728–738, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Kobayashi, Y. Kadono, A. Naito et al., “Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis,” EMBO Journal, vol. 20, no. 6, pp. 1271–1280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. B. R. Wong, D. Besser, N. Kim et al., “TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src,” Molecular Cell, vol. 4, no. 6, pp. 1041–1049, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. B. R. Wong, R. Josien, S. Y. Lee, M. Vologodskaia, R. M. Steinman, and Y. Choi, “The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor,” The Journal of Biological Chemistry, vol. 273, no. 43, pp. 28355–28359, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. M. D. Jacobs and S. C. Harrison, “Structure of an IκBα/NF-κB complex,” Cell, vol. 95, no. 6, pp. 749–758, 1998. View at Publisher · View at Google Scholar
  47. M. L. Chaisson, D. G. Branstetter, J. M. Derry et al., “Osteoclast differentiation is impaired in the absence of inhibitor of κB kinase α,” Journal of Biological Chemistry, vol. 279, no. 52, pp. 54841–54848, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Iotsova, J. Caamaño, J. Loy, Y. Yang, A. Lewin, and R. Bravo, “Osteopetrosis in mice lacking NF-κB1 and NF-κB2,” Nature Medicine, vol. 3, no. 11, pp. 1285–1289, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Asagiri and H. Takayanagi, “The molecular understanding of osteoclast differentiation,” Bone, vol. 40, no. 2, pp. 251–264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin, “Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families,” Endocrine Reviews, vol. 20, no. 3, pp. 345–357, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Islam, H.-S. Bae, W.-J. Yoon et al., “Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP,” Journal of Cellular Physiology, vol. 229, no. 12, pp. 2166–2174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Zhang, C. Dou, J. Xu, and S. Dong, “DC-STAMP, the key fusion-mediating molecule in osteoclastogenesis,” Journal of Cellular Physiology, vol. 229, no. 10, pp. 1330–1335, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Courtial, J. J. Smink, O. N. Kuvardina, A. Leutz, J. R. Göthert, and J. Lausen, “Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP,” FASEB Journal, vol. 26, no. 2, pp. 523–532, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Yagi, T. Miyamoto, Y. Sawatani et al., “DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells,” Journal of Experimental Medicine, vol. 202, no. 3, pp. 345–351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Miyamoto, “The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity,” Modern Rheumatology, vol. 16, no. 6, pp. 341–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. S. L. Teitelbaum, “Bone resorption by osteoclasts,” Science, vol. 289, no. 5484, pp. 1504–1508, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Erlebacher, E. H. Filvaroff, S. E. Gitelman, and R. Derynck, “Toward a molecular understanding of skeletal development,” Cell, vol. 80, no. 3, pp. 371–378, 1995. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Everts, J. Delaissé, W. Korper, A. Niehof, G. Vaes, and W. Beertsen, “Degradation of collagen in the bone‐resorbing compartment underlying the osteoclast involves both cysteine‐proteinases and matrix metalloproteinases,” Journal of Cellular Physiology, vol. 150, no. 2, pp. 221–231, 1992. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Ishikawa, M. Kamiyama, N. Tani-Ishii et al., “Inhibition of osteoclast differentiation and bone resorption by cathepsin k antisense oligonucleotides,” Molecular Carcinogenesis, vol. 32, no. 2, pp. 84–91, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. B. D. Gelb, G.-P. Shi, H. A. Chapman, and R. J. Desnick, “Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency,” Science, vol. 273, no. 5279, pp. 1236–1238, 1996. View at Publisher · View at Google Scholar · View at Scopus
  61. D. Brömme, K. Okamoto, B. B. Wang, and S. Biroc, “Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts: functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme,” Journal of Biological Chemistry, vol. 271, no. 4, pp. 2126–2132, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Leung, M. Pickarski, Y. Zhuo, P. J. Masarachia, and L. T. Duong, “The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking,” Bone, vol. 49, no. 4, pp. 623–635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. V. Everts, D. C. Aronson, and W. Beertsen, “Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis,” Calcified Tissue International, vol. 37, no. 1, pp. 25–31, 1985. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Matsumoto, M. Kogawa, S. Wada et al., “Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1,” The Journal of Biological Chemistry, vol. 279, no. 44, pp. 45969–45979, 2004. View at Publisher · View at Google Scholar · View at Scopus